Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. (2021)

First Author: Dejnirattisai W
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.12.03.471045

PubMed Identifier: 34981049

Publication URI: http://europepmc.org/abstract/MED/34981049

Type: Journal Article/Review

Parent Publication: bioRxiv : the preprint server for biology